Pear Therapeutics' once-high-flying assets were split between fellow digital therapeutics maker Click and three other buyers in Thursday’s auction, according to a court filing; their purchases still have to be approved in a hearing scheduled for Monday
![](https://static.wixstatic.com/media/ea65d1_2d12e7f4fd264291a0c6527d05aba85a~mv2.jpg/v1/fill/w_147,h_82,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/ea65d1_2d12e7f4fd264291a0c6527d05aba85a~mv2.jpg)